EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sphingomyelin synthase-related protein is a regulator of serine palmitoyltransferase

Xiang Li, Zhiqiang Li, Yeun-Po Chiang, Tilla Worgall, Tade Souaiaia, Xian-Cheng Jiang

Journal of Lipid Research · 2025

DOI: 10.1016/j.jlr.2025.100908 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Lipid Research, 2025. Verfasst von Xiang Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, State University of New York Downstate Health Sciences University, Brooklyn, NY, USA. Hauptthemen laut MEDLINE: Serine C-Palmitoyltransferase, Transferases (Other Substituted Phosphate Groups). Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NHLBI NIH HHS, National Heart Lung and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sphingomyelin synthase-related protein (SMSr) belongs to the SMS family; however, it cannot synthesize SM. We reported that SMSr is a phosphatidylethanolamine-specific phospholipase C, which is associated with metabolic dysfunction-associated fatty liver disease (MAFLD). However, the mechanism is unknown. Based on hierarchical clustering of the samples from the human Genotype-Tissue Expression project, we found that SMSr and serine palmitoyltransferase (SPT), the key enzyme for sphingolipid biosynthesis, as well as certain sphingolipid metabolism-related genes, belong to the same co-expression cluster in the liver and adipose tissues. We also found that Smsr expression is positively associated with Sptlc1 and Sptlc2 expression in both tissues of both genders. In a mouse study, we found that Smsr overexpression induced while Smsr knockout (KO) (under a high-fat diet) reduced SPT activity, thus, influencing most of the tested sphingolipids. Further, we found that PE treatment reversed Smsr overexpression-mediated SPTLC2 upregulation. PE supplement also reduced liver microsome SPT activity in a dose-dependent manner. Furthermore, we demonstrated that SMSr interacts with SPTLC2 in vivo. Thus, SMSr, as a member in the sphingolipid biosynthesis pathway, regulates SPT. Perturbation of SPT activity has been linked to the prevention of MAFLD and cardiovascular diseases. However, the approach to finding an SPT-specific inhibitor, as a drug, has not been successful so far. Importantly, global Smsr KO mice are viable and healthy; therefore, inhibiting SPT activity by reducing PE, mediated by SMSr/PE-PLC activity, could provide a novel approach for preventing and treating MAFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Serine C-PalmitoyltransferaseTransferases (Other Substituted Phosphate Groups)AnimalsMiceHumansMaleMice, KnockoutFemaleLiverSphingolipidsMice, Inbred C57BLMembrane ProteinsNerve Tissue Proteins

Stichwörter der Autor:innen

PhosphatidylethanolaminePhosphatidylethanolamine-specific phospholipase CSerine PalmitoyltransferaseSphingolipid biosynthesisSphingomyelin Synthase Related Protein

Substanzen

Serine C-PalmitoyltransferaseTransferases (Other Substituted Phosphate Groups)SphingolipidsSGMS1 protein, humanMembrane ProteinsNerve Tissue Proteins

Autor:innen und Institutionen

  • Department of Cell Biology, State University of New York Downstate Health Sciences University, Brooklyn, NY, USA.
  • Department of Cell Biology, State University of New York Downstate Health Sciences University, Brooklyn, NY, USA; Molecular and Cellular Cardiology Program, VA New York Harbor Healthcare System, Brooklyn, NY, USA.
  • Department of Pathology, Columbia University, New York, NY, USA.
  • Department of Cell Biology, State University of New York Downstate Health Sciences University, Brooklyn, NY, USA. Electronic address: tade.souaiaia@downstate.edu.
  • Department of Cell Biology, State University of New York Downstate Health Sciences University, Brooklyn, NY, USA; Molecular and Cellular Cardiology Program, VA New York Harbor Healthcare System, Brooklyn, NY, USA. Elect…

Förderung

  • BLRD VA
  • NHLBI NIH HHS
  • National Heart Lung and Blood Institute
  • National Institutes of Health

Zitieren

APA

Li, X., Li, Z., Chiang, Y. P., Worgall, T., Souaiaia, T., & Jiang, X. C. (2025). Sphingomyelin synthase-related protein is a regulator of serine palmitoyltransferase. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2025.100908

Vancouver

Li X, Li Z, Chiang YP, Worgall T, Souaiaia T, Jiang XC. Sphingomyelin synthase-related protein is a regulator of serine palmitoyltransferase. Journal of Lipid Research. 2025. doi:10.1016/j.jlr.2025.100908

BibTeX
@article{Li2025,
  author = {Li, Xiang and Li, Zhiqiang and Chiang, Yeun-Po and Worgall, Tilla and Souaiaia, Tade and Jiang, Xian-Cheng},
  title = {Sphingomyelin synthase-related protein is a regulator of serine palmitoyltransferase},
  journal = {Journal of Lipid Research},
  year = {2025},
  doi = {10.1016/j.jlr.2025.100908}
}
Kostenlos starten →